Empower Cells, Change Lives
Recent News
Triumvira Immunologics Demonstrates Prolonged TAC-T Cell Persistence and Efficacy in Preclinical Models
AUSTIN, Texas & HAMILTON, Ontario & TORONTO--(BUSINESS WIRE)--Triumvira Immunologics Inc. (Triumvira), announced the presentation of key preclinical data at the American Society of Hematology (ASH) 60th Annual Meeting and Exposition, held December 1-4, 2018,...
read moreTriumvira Immunologics Announces Presentation of Key Preclinical Data on TAC Technology at American Society of Hematology
AUSTIN, Texas & HAMILTON, Ontario & TORONTO--Triumvira Immunologics Inc. (Triumvira), announced the upcoming presentation of key preclinical data at the American Society of Hematology (ASH) 60th Annual Meeting and Exposition, December 1-4, 2018, in San Diego,...
read moreCCAB And Triumvira Immunologics Announce Triumvira’s License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates
AUSTIN, Texas & HAMILTON, Ontario & TORONTO--(BUSINESS WIRE)--The Centre for the Commercialization of Antibodies and Biologics (CCAB) and Triumvira Immunologics, Inc. (Triumvira), announced today a new licensing agreement between the University of Toronto (U...
read more